Auven Therapeutics
Finance · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
475 NE 1st St Ste A, Delray Beach, Flori...Phone Number
(954) 908-2360Website
www.auventx.comRevenue
$6.7 MillionIndustry
About Auven Therapeutics
Auven Therapeutics is an international private equity firm that acquires and pursues accelerated development of breakthrough drugs prior to licensing to commercial partners. Auven's in-house team of senior pharmaceutical development executives establishes the preclinical, clinical, regulatory, manufacturing and commercial strategies for all its products and oversees their execution. Auven was founded in 2008 by Stephen Evans-Freke and Dr. Peter B. Corr and maintains operations in Lausanne, Ft. Lauderdale, New Jersey, Bermuda, and the U.S. Virgin Islands.Explore more
SIC Code 61,615NAICS Code 52,523Show moreAuven Therapeutics Org Chart
Compare Similar Companies to Auven Therapeutics
Compare insights from companies similar to Auven Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Auven Therapeutics Tech Stack
A closer look at the technologies used by Auven Therapeutics
See more technologies
Top Finance Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Auven Therapeutics
Sign Up For FreeTo access detailed company insights
Auven Therapeutics is an international private equity firm that acquires and pursues accelerated development of breakthrough drugs prior to licensing to commercial partners. Auven's in-house team of senior pharmaceutical development executives establishes the preclinical, clinical, regulatory, manufacturing and commercial strategies for all its pro... Read More